These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 15691023

  • 1. Umbelliferone aminoalkyl derivatives as inhibitors of oxidosqualene cyclases from Saccharomyces cerevisiae, Trypanosoma cruzi, and Pneumocystis carinii.
    Oliaro-Bosso S, Viola F, Matsuda S, Cravotto G, Tagliapietra S, Balliano G.
    Lipids; 2004 Oct; 39(10):1007-12. PubMed ID: 15691023
    [Abstract] [Full Text] [Related]

  • 2. Inhibitory effect of umbelliferone aminoalkyl derivatives on oxidosqualene cyclases from S. cerevisiae, T. cruzi, P. carinii, H. sapiens, and A. thaliana: a structure-activity study.
    Oliaro-Bosso S, Viola F, Taramino S, Tagliapietra S, Barge A, Cravotto G, Balliano G.
    ChemMedChem; 2007 Feb; 2(2):226-33. PubMed ID: 17154325
    [Abstract] [Full Text] [Related]

  • 3. Oxidosqualene cyclase from Saccharomyces cerevisiae, Trypanosoma cruzi, Pneumocystis carinii and Arabidopsis thaliana expressed in yeast: a model for the development of novel antiparasitic agents.
    Balliano G, Dehmlow H, Oliaro-Bosso S, Scaldaferri M, Taramino S, Viola F, Caron G, Aebi J, Ackermann J.
    Bioorg Med Chem Lett; 2009 Feb 01; 19(3):718-23. PubMed ID: 19119009
    [Abstract] [Full Text] [Related]

  • 4. Analogs of squalene and oxidosqualene inhibit oxidosqualene cyclase of Trypanosoma cruzi expressed in Saccharomyces cerevisiae.
    Oliaro-Bosso S, Ceruti M, Balliano G, Milla P, Rocco F, Viola F.
    Lipids; 2005 Dec 01; 40(12):1257-62. PubMed ID: 16477810
    [Abstract] [Full Text] [Related]

  • 5. Design, synthesis, and biological evaluation of new (2E,6E)-10-(dimethylamino)-3,7-dimethyl-2,6-decadien-1-ol ethers as inhibitors of human and Trypanosoma cruzi oxidosqualene cyclase.
    Galli U, Oliaro-Bosso S, Taramino S, Venegoni S, Pastore E, Tron GC, Balliano G, Viola F, Sorba G.
    Bioorg Med Chem Lett; 2007 Jan 01; 17(1):220-4. PubMed ID: 17027267
    [Abstract] [Full Text] [Related]

  • 6. Subcellular localization of oxidosqualene cyclases from Arabidopsis thaliana, Trypanosoma cruzi, and Pneumocystis carinii expressed in yeast.
    Milla P, Viola F, Oliaro Bosso S, Rocco F, Cattel L, Joubert BM, LeClair RJ, Matsuda SP, Balliano G.
    Lipids; 2002 Dec 01; 37(12):1171-6. PubMed ID: 12617471
    [Abstract] [Full Text] [Related]

  • 7. Umbelliferone aminoalkyl derivatives as inhibitors of human oxidosqualene-lanosterol cyclase.
    Oliaro-Bosso S, Taramino S, Viola F, Tagliapietra S, Ermondi G, Cravotto G, Balliano G.
    J Enzyme Inhib Med Chem; 2009 Apr 01; 24(2):589-98. PubMed ID: 18830877
    [Abstract] [Full Text] [Related]

  • 8. Umbelliferone aminoalkyl derivatives, a new class of squalene-hopene cyclase inhibitors.
    Cravotto G, Balliano G, Tagliapietra S, Palmisano G, Penoni A.
    Eur J Med Chem; 2004 Nov 01; 39(11):917-24. PubMed ID: 15501540
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Vinyl sulfide derivatives of truncated oxidosqualene as selective inhibitors of oxidosqualene and squalene-hopene cyclases.
    Ceruti M, Balliano G, Rocco F, Milla P, Arpicco S, Cattel L, Viola F.
    Lipids; 2001 Jun 01; 36(6):629-36. PubMed ID: 11485168
    [Abstract] [Full Text] [Related]

  • 11. Novel squalene-hopene cyclase inhibitors derived from hydroxycoumarins and hydroxyacetophenones.
    Cravotto G, Balliano G, Tagliapietra S, Oliaro-Bosso S, Nano GM.
    Chem Pharm Bull (Tokyo); 2004 Oct 01; 52(10):1171-4. PubMed ID: 15467228
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. NMR Biochemical Assay for Oxidosqualene Cyclase: Evaluation of Inhibitor Activities on Trypanosoma cruzi and Human Enzymes.
    Tani O, Akutsu Y, Ito S, Suzuki T, Tateishi Y, Yamaguchi T, Niimi T, Namatame I, Chiba Y, Sakashita H, Kubota T, Yanagi T, Mizukami S, Hirayama K, Furukawa K, Yamasaki K.
    J Med Chem; 2018 Jun 14; 61(11):5047-5053. PubMed ID: 29771525
    [Abstract] [Full Text] [Related]

  • 14. Oxidosqualene cyclase inhibitors as antimicrobial agents.
    Hinshaw JC, Suh DY, Garnier P, Buckner FS, Eastman RT, Matsuda SP, Joubert BM, Coppens I, Joiner KA, Merali S, Nash TE, Prestwich GD.
    J Med Chem; 2003 Sep 25; 46(20):4240-3. PubMed ID: 13678402
    [Abstract] [Full Text] [Related]

  • 15. 29-Methylidene-2,3-oxidosqualene derivatives as stereospecific mechanism-based inhibitors of liver and yeast oxidosqualene cyclase.
    Ceruti M, Rocco F, Viola F, Balliano G, Milla P, Arpicco S, Cattel L.
    J Med Chem; 1998 Feb 12; 41(4):540-54. PubMed ID: 9484504
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Aminopropylindenes derived from Grundmann's ketone as a novel chemotype of oxidosqualene cyclase inhibitors.
    Lange S, Keller M, Müller C, Oliaro-Bosso S, Balliano G, Bracher F.
    Eur J Med Chem; 2013 May 12; 63():758-64. PubMed ID: 23583910
    [Abstract] [Full Text] [Related]

  • 18. Design strategies of oxidosqualene cyclase inhibitors: Targeting the sterol biosynthetic pathway.
    Rabelo VW, Romeiro NC, Abreu PA.
    J Steroid Biochem Mol Biol; 2017 Jul 12; 171():305-317. PubMed ID: 28479228
    [Abstract] [Full Text] [Related]

  • 19. Farnesyloxycoumarins, a new class of squalene-hopene cyclase inhibitors.
    Cravotto G, Balliano G, Robaldo B, Oliaro-Bosso S, Chimichi S, Boccalini M.
    Bioorg Med Chem Lett; 2004 Apr 19; 14(8):1931-4. PubMed ID: 15050630
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.